Home|Journals|Articles by Year|Audio Abstracts

Original Research

Diagnosis of pulmonary embolism in patients Mean Platelet Volume (MPV), neutrophil / lymphocyte ratio (NLR) and platelet / lymphocyte ratio (PLR) 's foresight

Ali Duman, Bekir Dagli, Kenan Ahmet Turkdogan, Mucahit Kapci, Guneri Kuruoz, Ayhan Akoz.


Pulmonary thromboembolic (PTE) is a disease the mortality and the incidence of which is high.Diagnosing PTE can be overlooked because PTE hasn’t a hard and an original clinic tableau. Recently, new marker studies continue in the diagnosis and the mortality prudence of MPV, NLR and PLR in pulmonary embolic diagnosis. Also, in our study we purposed to search the foresight of MPV, NLR and PLR in the diagnosis of pulmonary embolic. Through the patients who applied to our emergency room between 1 January 2014 and 1 January 2015, 42 patients diagnosed with pulmonary thromboembolic were taken by scanning retrospective. Thirty healthy people were taken to study for control group. The average age of 42 patients taken to study was 67,90 ± 14,85. 24 (%57,1) of patients are women and 18 (%42,9) of are men. The average D-dimer of patients was 5052,40 ± 5839,95 , the average PLR was 0,19 ± 0,12 , the average NLR was 8,07 ± 6,00 and the average MPV was 9,95 ± 1,01. In the control group, the average PLR was 0,18 ± 0,19 , the average NLR was 4,34 ± 4,26 and the average MPV was 8,79 ± 0,57. The average MPV, NLR and PLR of patient’s group was higher than control group’s. When comparing the patients’ and the control’s group , NLR and MPV was signficantly high (p< 0.005) but PLR was not significantly high. In our study when we compare the group of patients and control, NLR was significantly high but PLR wasn’t.

Key words: Pulmonary thromboemboli, MPV, NLR, PLR

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.